Eledon Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€13.36
Target price
23.01.22
€100.00
Performance (%)
-77.10%
End price
24.01.22
€3.06
Summary
This prediction ended on 24.01.22 with a price of €3.06. The BUY prediction by Maxi_Scalibusa for Eledon Pharmaceuticals Inc. performed very badly with a performance of -77.10%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eledon Pharmaceuticals Inc. | 10.476% | 10.476% | -30.120% | 7.407% |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % | 51,20 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % | 93,73 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % | 51,19 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % | 65,29 % |
According to Maxi_Scalibusa what are the pros and cons of Eledon Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Novus Therapeutics Inc. diskutieren
Buy mit Kursziel 100,0
In the thread Trading Novus Therapeutics Inc.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten


